Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses

Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses

Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa fever or Bolivian and Venezuelan hemorrhagic fevers are yet to be licensed for a use in humans. In th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:M.S. Médecine sciences 2023-11, Vol.39 (11), p.855-861
Hauptverfasser: Mateo, Mathieu, Baize, Sylvain
Format: Artikel
Sprache:fre
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 861
container_issue 11
container_start_page 855
container_title M.S. Médecine sciences
container_volume 39
creator Mateo, Mathieu
Baize, Sylvain
description Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa fever or Bolivian and Venezuelan hemorrhagic fevers are yet to be licensed for a use in humans. In this synthesis, we present the arenaviruses causing fatal diseases in humans and the main vaccine candidates that have been developed over the past decades with an emphasis on the measles-Lassa vaccine, the first Lassa vaccine ever tested in humans, and on the MOPEVAC platform that can potentially be used as a pan-arenavirus vaccine platform.
doi_str_mv 10.1051/medsci/2023162
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2895262813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2895262813</sourcerecordid><originalsourceid>FETCH-LOGICAL-p118t-e426f8894f54fd62d3951fb9dbdb611d1ec4caeaafa099ba7a19b28eef329da13</originalsourceid><addsrcrecordid>eNotjE1LxDAURYMgOI5uXWfppk5e0tRkKYNfMCCIrsfX5GUaadPatAX_vSO6OlzO5TB2BeIGhIZNRz67uJFCKqjkCVuB1abQysAZO8_5UwgJWqoV-3glR2ni6BdMjjKPiU8NcU8Ltf3Q_bo-8AWdi-mo8YAx5Yk31PXj2OAhOh6O3zFzh3Mmz-tvjiMlXOJ43PmCnQZsM13-c83eH-7ftk_F7uXxeXu3KwYAMxVUyioYY8ugy-Ar6ZXVEGrra19XAB7IlQ4JMaCwtsZbBFtLQxSUtB5Brdn1X3cY-6-Z8rTvYnbUtpion_NeGqtlJQ0o9QPAqlnd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2895262813</pqid></control><display><type>article</type><title>Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses</title><source>Alma/SFX Local Collection</source><creator>Mateo, Mathieu ; Baize, Sylvain</creator><creatorcontrib>Mateo, Mathieu ; Baize, Sylvain</creatorcontrib><description>Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa fever or Bolivian and Venezuelan hemorrhagic fevers are yet to be licensed for a use in humans. In this synthesis, we present the arenaviruses causing fatal diseases in humans and the main vaccine candidates that have been developed over the past decades with an emphasis on the measles-Lassa vaccine, the first Lassa vaccine ever tested in humans, and on the MOPEVAC platform that can potentially be used as a pan-arenavirus vaccine platform.</description><identifier>EISSN: 1958-5381</identifier><identifier>DOI: 10.1051/medsci/2023162</identifier><language>fre</language><ispartof>M.S. Médecine sciences, 2023-11, Vol.39 (11), p.855-861</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Mateo, Mathieu</creatorcontrib><creatorcontrib>Baize, Sylvain</creatorcontrib><title>Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses</title><title>M.S. Médecine sciences</title><description>Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa fever or Bolivian and Venezuelan hemorrhagic fevers are yet to be licensed for a use in humans. In this synthesis, we present the arenaviruses causing fatal diseases in humans and the main vaccine candidates that have been developed over the past decades with an emphasis on the measles-Lassa vaccine, the first Lassa vaccine ever tested in humans, and on the MOPEVAC platform that can potentially be used as a pan-arenavirus vaccine platform.</description><issn>1958-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNotjE1LxDAURYMgOI5uXWfppk5e0tRkKYNfMCCIrsfX5GUaadPatAX_vSO6OlzO5TB2BeIGhIZNRz67uJFCKqjkCVuB1abQysAZO8_5UwgJWqoV-3glR2ni6BdMjjKPiU8NcU8Ltf3Q_bo-8AWdi-mo8YAx5Yk31PXj2OAhOh6O3zFzh3Mmz-tvjiMlXOJ43PmCnQZsM13-c83eH-7ftk_F7uXxeXu3KwYAMxVUyioYY8ugy-Ar6ZXVEGrra19XAB7IlQ4JMaCwtsZbBFtLQxSUtB5Brdn1X3cY-6-Z8rTvYnbUtpion_NeGqtlJQ0o9QPAqlnd</recordid><startdate>20231129</startdate><enddate>20231129</enddate><creator>Mateo, Mathieu</creator><creator>Baize, Sylvain</creator><scope>7X8</scope></search><sort><creationdate>20231129</creationdate><title>Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses</title><author>Mateo, Mathieu ; Baize, Sylvain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p118t-e426f8894f54fd62d3951fb9dbdb611d1ec4caeaafa099ba7a19b28eef329da13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mateo, Mathieu</creatorcontrib><creatorcontrib>Baize, Sylvain</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>M.S. Médecine sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mateo, Mathieu</au><au>Baize, Sylvain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses</atitle><jtitle>M.S. Médecine sciences</jtitle><date>2023-11-29</date><risdate>2023</risdate><volume>39</volume><issue>11</issue><spage>855</spage><epage>861</epage><pages>855-861</pages><eissn>1958-5381</eissn><abstract>Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa fever or Bolivian and Venezuelan hemorrhagic fevers are yet to be licensed for a use in humans. In this synthesis, we present the arenaviruses causing fatal diseases in humans and the main vaccine candidates that have been developed over the past decades with an emphasis on the measles-Lassa vaccine, the first Lassa vaccine ever tested in humans, and on the MOPEVAC platform that can potentially be used as a pan-arenavirus vaccine platform.</abstract><doi>10.1051/medsci/2023162</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1958-5381
ispartof M.S. Médecine sciences, 2023-11, Vol.39 (11), p.855-861
issn 1958-5381
language fre
recordid cdi_proquest_miscellaneous_2895262813
source Alma/SFX Local Collection
title Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20the%20development%20of%20vaccines%20against%20hemorrhagic%20fevers%20caused%20by%20arenaviruses&rft.jtitle=M.S.%20M%C3%A9decine%20sciences&rft.au=Mateo,%20Mathieu&rft.date=2023-11-29&rft.volume=39&rft.issue=11&rft.spage=855&rft.epage=861&rft.pages=855-861&rft.eissn=1958-5381&rft_id=info:doi/10.1051/medsci/2023162&rft_dat=%3Cproquest%3E2895262813%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2895262813&rft_id=info:pmid/&rfr_iscdi=true